Medication adherence, social support, and event-free survival in patients with heart failure.
Authors:
- Jia-Rong WuJWJia-Rong Wu
- Susan K. FrazierSFSusan K. Frazier
- Mary Kay RayensMRMary Kay Rayens
- Terry A. LennieTLTerry A. Lennie
- Misook L. ChungMCMisook L. Chung
- Debra K. MoserDMDebra K. Moser
- 1 January 2013
- journal article
- research article
- Published by American Psychological Association (APA) in Health Psychology
- Vol. 32 (6) , 637-646
Abstract
Medication adherence and perceived social support (PSS) are independent predictors of mortality in patients with heart failure (HF). However, the predictive power of the combination of medication adherence and PSS for hospitalization and death has not been investigated in patients with HF. The purpose of the study was to explore the combined influence of medication adherence and PSS for prediction of cardiac event-free survival in patients with HF. A total of 218 HF patients monitored medication adherence for 1-3 months and completed the Multidimensional Perceived Social Support Scale (MPSSS) at baseline. Medication adherence was measured using a valid and objective measure, the Medication Event Monitoring System (MEMS). Patients were followed for up to 3.5 years to collect data about cardiac event-free survival (i.e., cardiac emergency department visits, hospitalizations, and death). To test the association of the combination of medication adherence and PSS with outcomes, the interaction term of medication adherence and PSS was first entered in a Cox regression to predict outcomes. Second, patients were grouped using an evidence-based cutpoint of 88% for medication adherence from the MEMS data and a median score 71 of the MPSSS. Kaplan-Meier and Cox proportional hazards models were used to compare cardiac event-free survival among groups. Medication adherence and PSS were independent predictors of cardiac event-free survival (p = .006 and .021, respectively). Patients with medication nonadherence and lower PSS had a 3.5 times higher risk of cardiac events than those who were adherent and had higher PSS. Medication adherence mediated the relationship between PSS and cardiac event-free survival in this sample. Moreover, medication adherence and social support independently, and in combination, predicted cardiac event-free survival in patients with HF. Interventions to improve clinical outcomes should address medication adherence and social support.Keywords
Funding Information
- Philips Medical American Association of Critical Care
- American Heart Association
- University of Kentucky (M01RR02602)
- National Institutes of Health (R01 NR008567, 1P20NR010679)
This publication has 52 references indexed in Scilit:
- Perceived Social Support and HIV/AIDS Medication Adherence Among African American WomenQualitative Health Research, 2006
- A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy.Health Psychology, 2006
- Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialThe Lancet, 2005
- Stress, Social Support, Emotional Regulation, and Exacerbation of Diffuse Plaque PsoriasisPsychosomatics, 2005
- Low Perceived Social Support and Post–Myocardial Infarction Prognosis in the Enhancing Recovery in Coronary Heart Disease Clinical Trial: The Effects of TreatmentPsychosomatic Medicine, 2005
- Telephonic case-finding of major depression in a Medicaid chronic disease management program for diabetes and heart failureGeneral Hospital Psychiatry, 2005
- The Importance and Impact of Social Support on Outcomes in Patients With Heart FailureJournal of Cardiovascular Nursing, 2005
- Social Support and Locus of Control as Predictors of Adherence to Antidepressant Medication in an Elderly PopulationThe American Journal of Geriatric Psychiatry, 2005
- Prognostic Importance of Emotional Support for Elderly Patients Hospitalized With Heart FailureCirculation, 1998
- Correlates of Early Hospital Readmission or Death in Patients With Congestive Heart FailureThe American Journal of Cardiology, 1997